Keurig Dr Pepper (NASDAQ:KDP) Given “Hold” Rating at HSBC

HSBC reiterated their hold rating on shares of Keurig Dr Pepper (NASDAQ:KDP) in a report released on Tuesday, MarketBeat reports. The brokerage currently has a $30.00 target price on the stock, down from their prior target price of $42.00.

Several other brokerages have also recently issued reports on KDP. Barclays upped their target price on Keurig Dr Pepper from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Monday, July 28th. JPMorgan Chase & Co. dropped their target price on Keurig Dr Pepper from $39.00 to $38.00 and set an “overweight” rating for the company in a report on Thursday, July 17th. Finally, UBS Group lowered their price target on Keurig Dr Pepper from $42.00 to $40.00 and set a “buy” rating for the company in a report on Thursday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Keurig Dr Pepper has a consensus rating of “Moderate Buy” and a consensus target price of $38.77.

Keurig Dr Pepper Stock Down 6.9%

NASDAQ KDP opened at $28.95 on Tuesday. The business has a fifty day moving average price of $33.59 and a 200 day moving average price of $33.64. Keurig Dr Pepper has a one year low of $28.93 and a one year high of $38.28. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.40 and a current ratio of 0.64. The company has a market cap of $39.33 billion, a P/E ratio of 25.85, a P/E/G ratio of 2.22 and a beta of 0.45.

Keurig Dr Pepper (NASDAQ:KDP) last posted its quarterly earnings data on Thursday, July 24th. The company reported $0.49 EPS for the quarter, meeting the consensus estimate of $0.49. The firm had revenue of $4.16 billion during the quarter, compared to the consensus estimate of $4.14 billion. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The firm’s revenue was up 6.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.45 EPS. Research analysts anticipate that Keurig Dr Pepper will post 1.92 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Mary Beth Denooyer sold 12,000 shares of the business’s stock in a transaction that occurred on Thursday, July 17th. The stock was sold at an average price of $33.66, for a total value of $403,920.00. Following the transaction, the insider owned 82,511 shares of the company’s stock, valued at approximately $2,777,320.26. The trade was a 12.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director De Ven Michael G. Van purchased 15,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 4th. The stock was acquired at an average price of $33.20 per share, for a total transaction of $498,000.00. Following the completion of the purchase, the director owned 15,000 shares of the company’s stock, valued at approximately $498,000. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold 679,601 shares of company stock worth $22,508,712 in the last quarter. 1.00% of the stock is owned by insiders.

Institutional Investors Weigh In On Keurig Dr Pepper

Institutional investors have recently added to or reduced their stakes in the company. China Universal Asset Management Co. Ltd. boosted its position in shares of Keurig Dr Pepper by 51.8% in the first quarter. China Universal Asset Management Co. Ltd. now owns 33,510 shares of the company’s stock worth $1,154,000 after buying an additional 11,435 shares during the period. Praxis Investment Management Inc. raised its stake in Keurig Dr Pepper by 112.2% during the first quarter. Praxis Investment Management Inc. now owns 19,630 shares of the company’s stock valued at $672,000 after buying an additional 10,380 shares in the last quarter. Aspire Private Capital LLC acquired a new stake in shares of Keurig Dr Pepper during the 1st quarter worth approximately $1,177,000. Envestnet Asset Management Inc. raised its position in shares of Keurig Dr Pepper by 13.7% during the 1st quarter. Envestnet Asset Management Inc. now owns 2,823,185 shares of the company’s stock worth $96,609,000 after purchasing an additional 339,530 shares during the period. Finally, Oppenheimer Asset Management Inc. raised its position in shares of Keurig Dr Pepper by 656.1% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 205,556 shares of the company’s stock worth $7,034,000 after purchasing an additional 178,368 shares during the period. Hedge funds and other institutional investors own 93.99% of the company’s stock.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.